Show Stocks and Investing Publications • Thu, March 30, 2023
Robert Burns Reiterated (BNTX) at Strong Buy and Held Target at $210 on, Mar 30th, 2023
s-reiterated-bntx-at-strong-buy-and-held-target-at-210-on-mar-30th-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIRobert Burns of HC Wainwright & Co., Reiterated "BioNTech SE" (BNTX) at Strong Buy and Held Target at $210 on, Mar 30th, 2023.
Robert has made no other calls on BNTX in the last 4 months.
There are 7 other peers that have a rating on BNTX. Out of the 7 peers that are also analyzing BNTX, 5 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $140 on, Tuesday, March 28th, 2023
- Matthew Korn of "Morgan Stanley" Maintained at Hold with Decreased Target to $150 on, Tuesday, March 28th, 2023
- Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $130 on, Tuesday, March 28th, 2023
- Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $142 on, Wednesday, February 8th, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $216 on, Tuesday, January 24th, 2023
These are the ratings of the 2 analyists that currently disagree with Robert
- Bill Selesky of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $203 on, Tuesday, March 28th, 2023
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $194 on, Tuesday, March 28th, 2023
Like: 👍